Today's announcement provided more evidence to support a bright forecast for BOT's future.
However, after witnessing the recent fiasco with RAP (for long term holders), this has me speculating what the future roadmap could look like. I for one profited well from a short-term hold of RAP, but long-term holders whom bought high were sold out to Big Pharma, which for some cases resulted in a significant loss.
What are the chances of BOT selling out to Big Pharma, versus BOT actually making it to production/distribution on it's own accord?
Keen to hear other investor's thoughts, albeit acknowledge any response is pure speculation at this stage.
Chris.
Today's announcement provided more evidence to support a bright...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 44.5¢ | 41.5¢ | $2.435M | 5.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 819538 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 29052 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |